Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1994 2
1995 2
1997 2
1998 1
2000 1
2002 1
2008 2
2009 3
2010 4
2011 4
2012 1
2013 2
2014 3
2015 4
2016 2
2017 1
2018 3
2019 2
2020 2
2021 2
2023 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Mehta G, Riva A, Ballester MP, Uson E, Pujadas M, Carvalho-Gomes Â, Sahuco I, Bono A, D'Amico F, Viganò R, Diago E, Lanseros BT, Inglese E, Vazquez DM, Sharma R, Tsou HLP, Harris N, Broekhoven A, Kikkert M, Morales SPT, Myeni SK, Riveiro-Barciela M, Palom A, Zeni N, Brocca A, Cussigh A, Cmet S, Escudero-García D, Stocco M, Natola LA, Ieluzzi D, Paon V, Sangiovanni A, Farina E, di Benedetto C, Sánchez-Torrijos Y, Lucena-Varela A, Román E, Sánchez E, Sánchez-Aldehuelo R, López-Cardona J, Canas-Perez I, Eastgate C, Jeyanesan D, Morocho AE, Di Cola S, Lapenna L, Zaccherini G, Bongiovanni D, Zanaga P, Sayaf K, Hossain S, Crespo J, Robles-Díaz M, Madejón A, Degroote H, Fernández J, Korenjak M, Verhelst X, García-Samaniego J, Andrade RJ, Iruzubieta P, Wright G, Caraceni P, Merli M, Patel VC, Gander A, Albillos A, Soriano G, Donato MF, Sacerdoti D, Toniutto P, Buti M, Duvoux C, Grossi PA, Berg T, Polak WG, Puoti M, Bosch-Comas A, Belli L, Burra P, Russo FP, Coenraad M, Calleja JL, Perricone G, Berenguer M, Claria J, Moreau R, Arroyo V, Angeli P, Sánchez C, Ampuero J, Piano S, Chokshi S, Jalan R; COBALT Consortium. Mehta G, et al. Among authors: madejon a. Hepatol Commun. 2023 Oct 18;7(11):e0273. doi: 10.1097/HC9.0000000000000273. eCollection 2023 Nov 1. Hepatol Commun. 2023. PMID: 37870985 Free PMC article.
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J, Gonzalez-Jimenez A, Alvarez-Alvarez I, Slim M, Jimenez-Perez M, Gonzalez-Grande R, Fernández MC, Casado M, Soriano G, Román E, Hallal H, Romero-Gomez M, Castiella A, Conde I, Prieto M, Moreno-Planas JM, Giraldez A, Moreno-Sanfiel JM, Kaplowitz N, Lucena MI, Andrade RJ; Participating clinical centres. Stephens C, et al. J Hepatol. 2021 Jul;75(1):86-97. doi: 10.1016/j.jhep.2021.01.029. Epub 2021 Feb 1. J Hepatol. 2021. PMID: 33539847 Free article.
Clinical significance of occult hepatitis B virus infection.
Romero M, Madejón A, Fernández-Rodríguez C, García-Samaniego J. Romero M, et al. Among authors: madejon a. World J Gastroenterol. 2011 Mar 28;17(12):1549-52. doi: 10.3748/wjg.v17.i12.1549. World J Gastroenterol. 2011. PMID: 21472119 Free PMC article. Review.
Emerging drugs for hepatitis C.
Soriano V, Madejon A, Vispo E, Labarga P, Garcia-Samaniego J, Martin-Carbonero L, Sheldon J, Bottecchia M, Tuma P, Barreiro P. Soriano V, et al. Among authors: madejon a. Expert Opin Emerg Drugs. 2008 Mar;13(1):1-19. doi: 10.1517/14728214.13.1.1. Expert Opin Emerg Drugs. 2008. PMID: 18321145 Review.
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients.
Medrano J, Barreiro P, Resino S, Tuma P, Rodríguez V, Vispo E, Labarga P, Madejón A, García-Samaniego J, Jiménez-Nácher I, Martín-Carbonero L, Soriano V. Medrano J, et al. Among authors: madejon a. Clin Infect Dis. 2009 Nov 1;49(9):1397-401. doi: 10.1086/630205. Clin Infect Dis. 2009. PMID: 19814621
Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.
Morello J, Cuenca L, Soriano V, Medrano J, Madejón A, Vispo E, Barreiro P, Labarga P, Jiménez-Nácher I, Rodríguez-Nóvoa S. Morello J, et al. Among authors: madejon a. J Infect Dis. 2010 Oct 15;202(8):1185-91. doi: 10.1086/656334. J Infect Dis. 2010. PMID: 20812847
Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells.
García-Crespo C, Francisco-Recuero I, Gallego I, Camblor-Murube M, Soria ME, López-López A, de Ávila AI, Madejón A, García-Samaniego J, Domingo E, Sánchez-Pacheco A, Perales C. García-Crespo C, et al. Among authors: madejon a. Front Cell Infect Microbiol. 2023 Mar 13;13:1057082. doi: 10.3389/fcimb.2023.1057082. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36992689 Free PMC article.
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease.
Palom A, Sopena S, Riveiro-Barciela M, Carvalho-Gomes A, Madejón A, Rodriguez-Tajes S, Roade L, García-Eliz M, García-Samaniego J, Lens S, Berenguer-Hayme M, Rodríguez-Frías F, Hernandez-Évole H, Isabel Gil-García A, Barreira A, Esteban R, Buti M. Palom A, et al. Among authors: madejon a. Aliment Pharmacol Ther. 2021 Aug;54(4):462-469. doi: 10.1111/apt.16485. Epub 2021 Jun 28. Aliment Pharmacol Ther. 2021. PMID: 34181772
47 results